Clinical Trials on HIV Infection in Switzerland

Total 1047 results

Goldhahn Jörg

Completed

Spread and Course of COVID-19 Infections (CoV-ETH)

Covid-19 | Virus Disease

Switzerland
University Hospital, Basel, Switzerland
Botnar Research Centre for Child Health

Completed

Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19

COVID-19 Disease

Switzerland
University Hospital, Basel, Switzerland

Completed

COVID-19 Survival - The COVIVA Study (COVIVA)

COVID-19 | SARS-CoV 2

Switzerland
University Hospital, Basel, Switzerland

Completed

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

Covid19 | SARS-CoV-2

Switzerland
University Hospital, Basel, Switzerland

Completed

Diagnosing of Acute Tuberculosis (SwEaTB)

Tuberculosis

Switzerland
AbbVie

Completed

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) (HEMATITE)

Chronic Hepatitis C Virus (HCV)

Switzerland
University Hospital, Geneva

Recruiting

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines (Pertagen2x)

Pertussis | Vaccine-Preventable Diseases

Switzerland
Hervé SPECHBACH
OM Pharma SA

Completed

Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. (COVID-19)

COVID-19 Virus Disease

Switzerland
Regina Grossmann

Terminated

USZ BioResource COVID-19

COVID19

Switzerland
University Hospital, Geneva

Completed

Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu)

Pneumonia | Covid19

Switzerland
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

MRI-based 3D Hip Labrum and Cartilage Morphology in Patients With Hip Deformities Compared to Asymptomatic Volunteers

Hip Disease

Switzerland
University Hospital, Basel, Switzerland

Terminated

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine (SASL28)

Hepatitis, Chronic

Switzerland
University of Zurich
Swiss School of Public Health (SSPH+)

Recruiting

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children (CiaoCorona)

COVID-19 | SARS-CoV 2

Switzerland
University Hospital Inselspital, Berne

Terminated

Daptomycin in Pediatric Patients With Bacterial Meningitis

Meningitis

Switzerland
GlycoVaxyn AG

Completed

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Shigellosis

Switzerland
University Hospital Inselspital, Berne
ETH Zurich

Completed

WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories (WAVE)

SARS-CoV 2 | COVID 19 | COVID

Switzerland
Hôpital du Valais

Recruiting

Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study

COVID-19 | Dysfunctional Breathing

Switzerland
Bristol-Myers Squibb
Basel Institute of Clinical Epidemiology (BICE)

Completed

Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

Hepatitis C

Switzerland
Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

Smallpox

Switzerland
Pevion Biotech Ltd

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Chronic Hepatitis C

Switzerland
Swiss Paraplegic Research, Nottwil
Swiss Spinal Cord Injury Cohort Study (SwiSCI)

Completed

Immunomodulation Therapy for Urinary Tract Infections (UROVAXOM-P)

Urinary Tract Infections | Spinal Cord Injuries

Switzerland
University Hospital, Basel, Switzerland
University of Basel; Swiss Federal Institute of Technology; University Children...

Completed

Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Influenza

Switzerland
Pivot Medical Inc.

Completed

Balloon Assisted Hip Arthroscopy - Clinical Evaluation of a New Tool for Hip Arthroscopy (BAHA-I)

Hip Arthroscopy

Belgium, Switzerland, United Kingdom
University of Zurich

Active, not recruiting

The RIsk Stratification in COVID-19 Patients in the ICU Registry (RISC-19-ICU)

COVID-19 | Critical Illness | Inflammatory Response | ARDS | Circulatory Shock

Switzerland
Centre Hospitalier Universitaire Vaudois
GlaxoSmithKline; University of Lausanne; University of Lausanne Hospitals; World... and other collaborators

Completed

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Ebola Vaccines

Switzerland
Johannes Scherr

Recruiting

GRIP: Maximum Isometric Grip Strength Assessed With Three Different Hand-held Dynamometers

Grip

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

Tuberculosis, Pulmonary

Switzerland
University of Zurich
University Hospital, Geneva; University Hospital, Basel, Switzerland; University... and other collaborators

Recruiting

The SwissPrEPared Study

HIV Preexposure Prophylaxis

Switzerland
ViiV Healthcare

Not yet recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy (VOGUE)

HIV Infections | HIV

Spain, Poland, France, Israel, Belgium, Portugal, Germany, Italy, Argentina, Greece, Japan, Ireland, Switzerland, United Kingdom, Denmark, Sweden, Mexico
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine (MERIT)

HIV-1

United States, Canada, United Kingdom, Netherlands, Argentina, Australia, Belgium, South Africa, Switzerland, Italy, Puerto Rico, Brazil, Mexico, Poland
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
A. Vogel AG
University Children's Hospital, Zurich

Withdrawn

Echinaforce Junior Bioavailability Trial

Common Cold

Switzerland
Klara M. Pósfay Barbe
University Hospital, Geneva

Recruiting

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients (MMRinOLT)

Measles

Switzerland
University Hospital, Basel, Switzerland

Completed

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine (MACIS)

Myocarditis

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Tuberculosis | Tuberculosis, Pulmonary

Switzerland
Novartis Vaccines

Completed

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
University of Zurich
Wroclaw Medical University

Unknown

The Global PCHF-COVICAV Registry (PCHF-COVICAV)

Cardiovascular Diseases | Heart Failure | COVID-19 | Cardiovascular Risk Factor

Switzerland
University of Geneva, Switzerland
Inovio Pharmaceuticals; Defense Advanced Research Projects Agency; Global Urgent...

Completed

INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees (Boost-EBOV)

Ebola Virus Disease

Switzerland
University of Zurich

Completed

Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients (Vit B12)

Bacteremia

Switzerland
Ente Ospedaliero Cantonale, Bellinzona
Clinical Trial Unit Ente Ospedaliero Cantonale; Swiss Transfusion SRC

Completed

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

Hepatitis E

Switzerland
University Hospital, Geneva
Fonds national Suisse

Completed

Congenital Syphilis in Switzerland

Congenital Syphilis

Switzerland

3

Subscribe